Trial Profile
An Open-Label Phase 1 Study to Evaluate the Pharmacokinetics of Intranasal Esketamine Administered With and Without a Nasal Guide on the Intranasal Device
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Feb 2014
Price :
$35
*
At a glance
- Drugs Esketamine (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Janssen
- 24 Feb 2014 New trial record